Fbr & Co. Common Stk (FBRC) 18.03 $FBRC Voce Reminds FBR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fbr & Co. Common Stk (FBRC) 18.03 $FBRC

Voce Reminds FBR Shareholders to Vote Today on BLUE Proxy Card for Its Board Nominees
BusinessWire - Fri Jun 10, 8:48AM CDT
--Reiterates the Time is Now to Reclaim FBR's Legacy and End Syndrome of Strategic Misfires and Underperformance
FBRC: 18.03 (-0.70)

All Three Proxy Advisory Firms Support Voce's Call for Change at FBR
BusinessWire - Mon Jun 06, 7:00AM CDT
--Follows Recent ISS and Glass Lewis Endorsements of Voce's Case for Change
FBRC: 18.03 (-0.70)

Glass Lewis Endorses Voce Case for Change at FBR
BusinessWire - Fri Jun 03, 10:52AM CDT
--Glass Lewis Notes FBR has Failed to Demonstrate "Sustainable Strategic Operating Path to Enhance Returns for Shareholders"
FBRC: 18.03 (-0.70)

FBR & Co. Comments on Glass Lewis Report
GlobeNewswire - Fri Jun 03, 8:14AM CDT
FBR & Co. (NASDAQ:FBRC) ("FBR" or the "Company" a leading investment bank serving the middle market, today issued the following statement in response to a recent report by Glass Lewis & Co ("Glass Lewis", relating to the election of directors to FBR's Board of Directors at the Company's upcoming Annual Meeting of Shareholders to be held on Tuesday, June 14, 2016.
FBRC: 18.03 (-0.70)

ISS Endorses All Voce Nominees for FBR's Board
BusinessWire - Thu Jun 02, 8:58AM CDT
--ISS Concludes that FBR has "Not Been Able to Implement a Successful Growth Strategy under Current Management"
FBRC: 18.03 (-0.70)

FBR & Co. Comments on ISS Report
GlobeNewswire - Thu Jun 02, 8:51AM CDT
FBR & Co. (NASDAQ:FBRC) ("FBR" or the "Company" a leading investment bank serving the middle market, today issued the following statement in response to a recent report by Institutional Shareholder Services Inc. ("ISS", relating to the election of directors to FBR's Board of Directors at the Company's upcoming Annual Meeting of Shareholders to be held on Tuesday, June 14, 2016.
FBRC: 18.03 (-0.70)

Voce Capital Issues Updated Presentation to FBR Shareholders
BusinessWire - Tue May 24, 8:00AM CDT
--Believes Continuous Strategy Shifts, as well as Undue Optimism, Missed Expectations and Selective, Misleading Disclosures, Have Eroded Board and Management Credibility and are Impediments to Shareholder Value
FBRC: 18.03 (-0.70)

Voce Capital Sends Letter To FBR Shareholders Outlining Urgent Need for Board Change
BusinessWire - Mon May 16, 8:00AM CDT
--Reveals FBR Insiders' Conflicting Interests and Creeping Efforts to Gain Control of the Company at the Expense of Other Shareholders
FBRC: 18.03 (-0.70)

Voce Capital Files Preliminary FBR Proxy Statement
BusinessWire - Tue May 03, 8:00AM CDT
Voce Capital Management LLC ("Voce", which along with its nominees owns 5.3% of FBR & Co. (Nasdaq:FBRC) ("FBR" or the "Company" and is the Company's third-largest shareholder, today announced that it has filed its preliminary proxy statement and intends to proceed with its nomination of three independent Directors for election to the Company's Board (the "Board" at the 2016 Annual Meeting of shareholders. Voce also released the following statement regarding recent developments at the Company, which Voce believes underscore the need for urgent change at FBR:
FBRC: 18.03 (-0.70)

FBR reports 1Q loss
Automated Insights - Wed Apr 27, 7:14AM CDT
ARLINGTON, Va. (AP) _ FBR & Co (FBRC) on Wednesday reported a loss of $5.5 million in its first quarter.
FBRC: 18.03 (-0.70)

FBR & Co. Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 7:05AM CDT
Declares $0.20 per Share Quarterly Cash Dividend
FBRC: 18.03 (-0.70)

Voce Capital Highlights FBR's Lack of Transparency and Credibility
BusinessWire - Mon Apr 18, 8:00AM CDT
--Voce Believes FBR's Refusal to be Transparent with Shareholders Demonstrates Further Lack of Accountability by Board and Management
FBRC: 18.03 (-0.70)

Chris Meekins Initiates Healthcare Policy Research at FBR
GlobeNewswire - Tue Apr 12, 8:00AM CDT
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced that Chris Meekins recently joined its equity research group and has initiated coverage on healthcare policy. Mr. Meekins is based in the Company's Arlington, VA headquarters.
FBRC: 18.03 (-0.70)

FBR to Report First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 06, 8:00AM CDT
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced today that it will release results for the first quarter of 2016 before the market opens on Wednesday, April 27, 2016.
FBRC: 18.03 (-0.70)

CorMedix Inc. to be Featured on Panel at FBR & Co. Healthcare Series Event Focused on Infectious Diseases
ACCESSWIRE - Wed Apr 06, 7:05AM CDT
New Prescriptions: Innovation in the Treatment of Diseases and Infections to be held April 20, 2016 in New York, NY
CRMD: 2.26 (-0.06), FBRC: 18.03 (-0.70)

FBR Announces Holden Lewis Joins Equity Research Team Focused on Industrial Technology
GlobeNewswire - Tue Apr 05, 3:05PM CDT
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced that Holden Lewis has joined its equity research group covering industrial technology within its Diversified Industrials Group.
FBRC: 18.03 (-0.70)

Voce Capital Issues Presentation Detailing Need for Change at FBR & Co.
BusinessWire - Tue Apr 05, 8:07AM CDT
--Believes Current Board and Management are Squandering FBR's Storied Heritage; New Leadership and Oversight Needed
FBRC: 18.03 (-0.70)

Voce Capital Nominates Three FBR Directors
BusinessWire - Mon Mar 21, 1:57PM CDT
--FBR's Current Strategy Disrespects its Heritage at the Expense of the Company, its Employees and Shareholders
CENX: 6.50 (-0.34), DLB: 47.75 (-0.20), CLCT: 19.32 (-0.13), LOV: 1.58 (unch), FBRC: 18.03 (-0.70)

FBR & Co. Announces the Addition of Michael McHugh to Investment Banking Team
GlobeNewswire - Thu Mar 03, 10:36AM CST
FBR & Co. (Nasdaq:FBRC) ("FBR" or the "Company", a leading investment bank serving the middle market, today announced that Michael McHugh has joined the Company's Investment Banking Team as Managing Director covering media and telecommunications. He is based in the Company's Arlington, VA office and is focused on providing the full suite of FBR's products to his client base.
FBRC: 18.03 (-0.70)

FBR & Co. Announces the Addition of Tina Pappas to Investment Banking Team
GlobeNewswire - Fri Feb 19, 10:13AM CST
FBR & Co. (Nasdaq:FBRC) ("FBR" or the "Company", a leading investment bank serving the middle market, today announced that Tina Pappas has joined the Company's Investment Banking Team as Managing Director. She is based in the Company's New York office and focused on developing the firm's Special Purpose Acquisition Company ("SPAC" practice.
FBRC: 18.03 (-0.70)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading